Statistical Evaluation of Environmental Factors as Diabetogenic Agent in Type 2 Diabetes Mellitus
Keywords:
Diabetes, Environmental factors, Demographic variables, Diabetes; Environmental factors; Pakistan; Demographic variables; statistics.Abstract
The purpose of this study was to analyze the environmental factors affecting individuals with diabetes. A study was conducted among diabetes patients at the Lahore General Hospital's outdoor clinic. Data was collected using a standardized questionnaire after getting approval of patients being interviewed. SPSS 25.0 was utilized for analysis. Total 1000 people were chosen, 500 of whom were diabetic patients and the rest were non-diabetic. Environmental factors were investigated in a 1000-person research of diabetics and non-diabetics. To determine the relationship between patients with diabetes and environmental factors, the Chi-Square test and Mann-Whitney test were used to compare the effects of age, BMI, and sugar level fasting. The findings reveal that environmental factors play crucial effects on patients in term of age, BMI, and sugar level. I also used the odds ratio on diabetic and non-diabetic patients who have the Stroke, TIA, hypertension, and other environmental factors. The study revealed that diabetes is more persistent in industrial and urban region as 60% of the population living in these areas are under risk of diabetes. Moreover, the results showed that nearly 62% tap water consumers in rural areas were diabetic while 38% filtered water consumers in urban areas were diabetic. Smoking caused diabetes in nearly 22% people, 28% people suffered due to utilization of homeopathic medicines while 35% diabetic patients were found multivitamin consumers. Furthermore, the study depicted that among 1000 individuals under study, 56 % females were diabetic due to environmental factors. Diabetes has a direct relationship with the environment experienced by a patient.
References
A. D. Association, “2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes—2020,” Diabetes Care, vol. 43, no. Supplement_1, pp. S14–S31, Jan. 2020, doi: 10.2337/DC20-S002.
B. C. R. LEUTHOLTZ, EXERCISE AND DISEASE MANAGEMENT. CRC Press, 2019.
A. E. Kitabchi, G. E. Umpierrez, J. M. Miles, and J. N. Fisher, “Hyperglycemic Crises in Adult Patients With Diabetes,” Diabetes Care, vol. 32, no. 7, p. 1335, Jul. 2009, doi: 10.2337/DC09-9032.
“Diabetes Home Remedies: How to Lower Blood Sugar Levels.” https://www.emedihealth.com/glands-hormones/diabetes/manage-diabetes (accessed Mar. 28, 2022).
V. Anand et al., “Islet Autoimmunity and HLA Markers of Presymptomatic and Clinical Type 1 Diabetes: Joint Analyses of Prospective Cohort Studies in Finland, Germany, Sweden, and the U.S,” Diabetes Care, vol. 44, no. 10, pp. 2269–2276, Oct. 2021, doi: 10.2337/DC20-1836.
“Chapter 17. Pancreatic Hormones and Diabetes Mellitus | Greenspan’s Basic & Clinical Endocrinology, 9e | AccessMedicine | McGraw Hill Medical.” https://accessmedicine.mhmedical.com/content.aspx?bookid=380§ionid=39744057 (accessed Mar. 28, 2022).
P. J. Donovan and H. David Mcintyre, “Drugs for gestational diabetes,” Aust. Prescr., vol. 33, no. 5, pp. 141–144, 2010, doi: 10.18773/AUSTPRESCR.2010.066.
R. Bonfanti et al., “Differences between transient neonatal diabetes mellitus subtypes can guide diagnosis and therapy,” Eur. J. Endocrinol., vol. 184, no. 4, pp. 575–585, Apr. 2021, doi: 10.1530/EJE-20-1030.
“Diabetes: the tale of two types » HealthStyle.” https://www.healthstyle.net.au/article/diabetes-the-tale-of-two-types/ (accessed Mar. 29, 2022).
A. D. Deshpande, M. Harris-Hayes, and M. Schootman, “Epidemiology of diabetes and diabetes-related complications,” Phys. Ther., vol. 88, no. 11, pp. 1254–1264, Nov. 2008, doi: 10.2522/PTJ.20080020.
A. Ceriello, “Hyperglycaemia and the vessel wall: the pathophysiological aspects on the atherosclerotic burden in patients with diabetes,” Eur. J. Cardiovasc. Prev. Rehabil., vol. 17 Suppl 1, no. SUPPL. 1, May 2010, doi: 10.1097/01.HJR.0000368193.24732.66.
J. Edwards and M. E. Beckman, “Methodological questions in studying consonant acquisition,” Clin. Linguist. Phon., vol. 22, no. 12, p. 937, 2008, doi: 10.1080/02699200802330223.
C. M. Casellini and A. I. Vinik, “Clinical manifestations and current treatment options for diabetic neuropathies,” Endocr. Pract., vol. 13, no. 5, pp. 550–566, 2007, doi: 10.4158/EP.13.5.550.
M. Eckhard, A. Lengler, J. Liersch, R. G. Bretzel, and P. Mayser, “Fungal foot infections in patients with diabetes mellitus--results of two independent investigations,” Mycoses, vol. 50 Suppl 2, no. SUPPL. 2, pp. 14–19, Sep. 2007, doi: 10.1111/J.1439-0507.2007.01425.X.
R. Hashemi, M. Rahimlou, S. Baghdadian, and M. Manafi, “Investigating the effect of DASH diet on blood pressure of patients with type 2 diabetes and prehypertension: Randomized clinical trial,” Diabetes Metab. Syndr., vol. 13, no. 1, pp. 1–4, Jan. 2019, doi: 10.1016/J.DSX.2018.06.014.
M. L. Larramendy and S. Soloneski, “Environmental Health Risk - Hazardous Factors to Living Species,” Environ. Heal. Risk - Hazard. Factors to Living Species, Jun. 2016, doi: 10.5772/61472.
Y. Bi et al., “Advanced research on risk factors of type 2 diabetes,” Diabetes. Metab. Res. Rev., vol. 28 Suppl 2, no. SUPPL.2, pp. 32–39, Dec. 2012, doi: 10.1002/DMRR.2352.
T. L. M. Hectors et al., “Environmental pollutants and type 2 diabetes: a review of mechanisms that can disrupt beta cell function,” Diabetologia, vol. 54, no. 6, pp. 1273–1290, Jun. 2011, doi: 10.1007/S00125-011-2109-5.
S. Chatterjee, K. Khunti, and M. J. Davies, “Type 2 diabetes,” Lancet (London, England), vol. 389, no. 10085, pp. 2239–2251, Jun. 2017, doi: 10.1016/S0140-6736(17)30058-2.
M. Schulz, M. Romppel, and G. Grande, “Built environment and health: a systematic review of studies in Germany,” J. Public Health (Oxf)., vol. 40, no. 1, pp. 8–15, Mar. 2018, doi: 10.1093/PUBMED/FDW141.
S. Rajagopalan and R. D. Brook, “Air pollution and type 2 diabetes: mechanistic insights,” Diabetes, vol. 61, no. 12, pp. 3037–3045, Dec. 2012, doi: 10.2337/DB12-0190.
A. Arab YarMohammadi, S. Arbabi Bidgoli, and P. Ziarati, “Increased urinary arsenic concentration in newly diagnosed type 2 diabetes mellitus: a gender-independent, smoking-dependent exposure biomarker in older adults in Tehran,” Environ. Sci. Pollut. Res. Int., vol. 28, no. 22, pp. 27769–27777, Jun. 2021, doi: 10.1007/S11356-020-10261-W.
M. T. Boden and S. Gala, “Exploring correlates of diabetes-related stress among adults with Type 1 diabetes in the T1D exchange clinic registry,” Diabetes Res. Clin. Pract., vol. 138, pp. 211–219, Apr. 2018, doi: 10.1016/J.DIABRES.2017.10.012.
Y. Huh, K. Han, M.-J. Choi, J. H. Kim, S. M. Kim, and G. E. Nam, “Association of Smoking Status With the Risk of Type 2 Diabetes Among Young Adults: A Nationwide Cohort Study in South Korea,” Nicotine Tob. Res., Feb. 2022, doi: 10.1093/NTR/NTAC044.
S. A. Meo, I. Zia, I. A. Bukhari, and S. A. Arain, “Type 2 diabetes mellitus in Pakistan: Current prevalence and future forecast.,” J. Pak. Med. Assoc., vol. 66, no. 12, pp. 1637–1642, Dec. 2016, Accessed: Mar. 29, 2022. [Online]. Available: https://europepmc.org/article/med/27924966.
K. Rangel-Moreno, B. Gamboa-Loira, L. López-Carrillo, and M. E. Cebrián, “Prevalence of type 2 diabetes mellitus in relation to arsenic exposure and metabolism in Mexican women,” Environ. Res., vol. 210, Jul. 2022, doi: 10.1016/J.ENVRES.2022.112948.
J. R Barrera, “Insulin Resistance among Adults with Type 1 Diabetes Mellitus at the Philippine General Hospital,” J. Diabetes Metab., vol. 04, no. 10, pp. 1–6, 2013, doi: 10.4172/2155-6156.1000315.
N. Ozdemir, A. Sahin, and A. Sahin, “Anxiety levels, quality of life and related socio-demographic factors in patients with type 2 diabetes,” Niger. J. Clin. Pract., vol. 23, no. 6, pp. 775–782, Jun. 2020, doi: 10.4103/NJCP.NJCP_523_19.
S. Riaz, “Obesity as a Risk Factor for Diabetes Mellitus in the Local Population of Pakistan,” Univers. J. Clin. Med., vol. 2, no. 3, pp. 58–64, Nov. 2014, doi: 10.13189/UJCM.2014.020302.
S. Riaz, “Evaluation and Analysis of Human Folate levels in Pakistani diabetic Population,” vol. 5, no. 12, pp. 1572–1576, 2014.
S. Riaz, “Study of protein biomarkers of diabetes mellitus type 2 and therapy with vitamin B1,” J. Diabetes Res., vol. 2015, 2015, doi: 10.1155/2015/150176.
S. Shahzad Alam, S. Riaz, and C. Borza, “Induction and Activities of Pyruvate Dehydrogenase and α-ketoglutarate Dehydrogenase in Type 2 Diabetic Patients and Therapy with Vitamin B1,” J. Adv. Med. Med. Res., vol. 12, no. 10, pp. 1–12, Jan. 2016, doi: 10.9734/BJMMR/2016/22530.
M. T. Mursleen and S. Riaz, “Implication of homocysteine in diabetes and impact of folate and vitamin B12 in diabetic population,” Diabetes Metab. Syndr., vol. 11 Suppl 1, pp. S141–S146, Nov. 2017, doi: 10.1016/J.DSX.2016.12.023.
S. Riaz, “Therapeutic Implication of Folate-Homocysteine Interaction in the Local Diabetic Pakistani Population,” vol. 2015, pp. 1–9, 2018.
S. Riaz, “Analysis of Pyridoxine in the Male Diabetic Population of Lahore and Sheikhupura,” Ann. Diabetes, Metab. Disord. Control, vol. 2, no. 1, pp. 118–127, 2018.
S. Riaz and M. Tariq, “Linkage of Micro Albuminuria and Serum Albumin Levels in the Diabetic Patients of Punjab University Premises,” vol. 2, no. 1, pp. 1–6, 2018.
“Association of Serum Protein Levels in the Diabetic Patients with Risk of Cardiovascular Disease and Nephropathy in Pakistani Population.” https://www.scireslit.com/Diabetes/JRDM-ID21.php (accessed Mar. 29, 2022).
Z. Joneidi, Y. Mortazavi, F. Memari, A. Roointan, B. Chahardouli, and S. Rostami, “The impact of genetic variation on metabolism of heavy metals: Genetic predisposition?,” Biomed. Pharmacother., vol. 113, May 2019, doi: 10.1016/J.BIOPHA.2019.108642.
M. S. Rahaman et al., “Environmental arsenic exposure and its contribution to human diseases, toxicity mechanism and management,” Environ. Pollut., vol. 289, Nov. 2021, doi: 10.1016/J.ENVPOL.2021.117940.
Y. Yang, L. Chi, Y. Lai, Y. C. Hsiao, H. Ru, and K. Lu, “The gut microbiome and arsenic-induced disease-iAs metabolism in mice,” Curr. Environ. Heal. reports, vol. 8, no. 2, pp. 89–97, Jun. 2021, doi: 10.1007/S40572-021-00305-9.
X. Li, X. Wang, and S. K. Park, “Associations between rice consumption, arsenic metabolism, and insulin resistance in adults without diabetes,” Int. J. Hyg. Environ. Health, vol. 237, Aug. 2021, doi: 10.1016/J.IJHEH.2021.113834.
Z. Rahman and V. P. Singh, “The relative impact of toxic heavy metals (THMs) (arsenic (As), cadmium (Cd), chromium (Cr)(VI), mercury (Hg), and lead (Pb)) on the total environment: an overview,” Environ. Monit. Assess., vol. 191, no. 7, Jul. 2019, doi: 10.1007/S10661-019-7528-7.
S. Mishra et al., “Heavy Metal Contamination: An Alarming Threat to Environment and Human Health,” Environ. Biotechnol. Sustain. Futur., pp. 103–125, 2019, doi: 10.1007/978-981-10-7284-0_5.
M. Al osman, F. Yang, and I. Y. Massey, “Exposure routes and health effects of heavy metals on children,” Biometals, vol. 32, no. 4, pp. 563–573, Aug. 2019, doi: 10.1007/S10534-019-00193-5.
Z. Fu and S. Xi, “The effects of heavy metals on human metabolism,” Toxicol. Mech. Methods, vol. 30, no. 3, pp. 167–176, Mar. 2020, doi: 10.1080/15376516.2019.1701594.
S. Tyagi, M. Siddarth, B. K. Mishra, B. D. Banerjee, A. J. Urfi, and S. V. Madhu, “High levels of organochlorine pesticides in drinking water as a risk factor for type 2 diabetes: A study in north India,” Environ. Pollut., vol. 271, Feb. 2021, doi: 10.1016/J.ENVPOL.2020.116287.
M. Hendryx, J. Luo, C. Chojenta, and J. E. Byles, “Exposure to heavy metals from point pollution sources and risk of incident type 2 diabetes among women: a prospective cohort analysis,” Int. J. Environ. Health Res., vol. 31, no. 4, pp. 453–464, 2021, doi: 10.1080/09603123.2019.1668545.
Y. L. Deng et al., “Associations between drinking water disinfection byproducts and menstrual cycle characteristics: A cross-sectional study among women attending an infertility clinic,” Int. J. Hyg. Environ. Health, vol. 241, p. 113931, Apr. 2022, doi: 10.1016/J.IJHEH.2022.113931.
N. J. Pillon, R. J. F. Loos, S. M. Marshall, and J. R. Zierath, “Metabolic consequences of obesity and type 2 diabetes: Balancing genes and environment for personalized care,” Cell, vol. 184, no. 6, pp. 1530–1544, Mar. 2021, doi: 10.1016/J.CELL.2021.02.012.
F. De la Fuente et al., “Green Space Exposure Association with Type 2 Diabetes Mellitus, Physical Activity, and Obesity: A Systematic Review,” Int. J. Environ. Res. Public Health, vol. 18, no. 1, pp. 1–18, Jan. 2020, doi: 10.3390/IJERPH18010097.
M. Luciani, L. Montali, G. Nicolò, D. Fabrizi, S. Di Mauro, and D. Ausili, “Self-care is Renouncement, Routine, and Control: The Experience of Adults with Type 2 Diabetes Mellitus,” Clin. Nurs. Res., vol. 30, no. 6, pp. 892–900, Jul. 2021, doi: 10.1177/1054773820969540.
M. Snobia, R. Samreen, A. Tooba, and R. Aasma, “Risk Factors Associated to Patients with Type 2 Diabetes in Lahore District,” Ann. Clin. Endocrinol. Metab., vol. 4, no. 1, pp. 011–019, May 2020, doi: 10.29328/JOURNAL.ACEM.1001014.
M. H. Afridi et al., “Active Smokers and the risk of type 2 diabetes Mellitus in urban and rural area of kpk,” Am. J. Heal. Med. Nurs. Pract., vol. 7, no. 2, pp. 24–28, Jan. 2022, doi: 10.47672/AJHMN.915.
T. Dendup, X. Feng, S. Clingan, and T. Astell-Burt, “Environmental Risk Factors for Developing Type 2 Diabetes Mellitus: A Systematic Review,” Int. J. Environ. Res. Public Health, vol. 15, no. 1, Jan. 2018, doi: 10.3390/IJERPH15010078.
S. A. Meo, Y. A. Bin Muneif, N. A. Benomran, M. A. Alsadhan, R. F. Hashem, and A. S. Alobaisi, “Prevalence of Pre Diabetes and Type 2 Diabetes Mellitus among cement industry workers,” Pakistan J. Med. Sci., vol. 36, no. 2, p. 32, Jan. 2020, doi: 10.12669/PJMS.36.2.1266.
A. Navas-Acien, E. K. Silbergeld, R. Pastor-Barriuso, and E. Guallar, “Arsenic exposure and prevalence of type 2 diabetes in US adults,” JAMA, vol. 300, no. 7, pp. 814–822, Aug. 2008, doi: 10.1001/JAMA.300.7.814.
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 50sea
This work is licensed under a Creative Commons Attribution 4.0 International License.